IRulya Therapeutics (IRLA) Shares Outstanding (Entity) (2018 - 2026)
IRulya Therapeutics (IRLA) reported Shares Outstanding (Entity) of 6.13 million for Q2 2026, compared with 268,121 a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
For FY2025, IRulya Therapeutics posted Shares Outstanding (Entity) of 278,626, up 26.6% from FY2024.
- Shares Outstanding (Entity) has increased for seven consecutive years, with a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 220,008 in FY2024 (+2.4%), 214,866 in FY2023 (+18.9%), 180,682 in FY2022 (+20.2%) and 150,372 in FY2021 (+1.8%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2018.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.6% (Q3 2023) to 106.9% (Q1 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at 456,013 (Q1 2026), 278,626 (Q4 2025) and 272,475 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.70 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 6.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.13 Mn |
| Mar 31, 2026 | 456,013.00 |
| Dec 31, 2025 | 278,626.00 |
| Sep 30, 2025 | 272,475.00 |
| Jun 30, 2025 | 268,121.00 |
| Mar 31, 2025 | 220,446.00 |
| Dec 31, 2024 | 220,008.00 |
| Sep 30, 2024 | 216,383.00 |
| Jun 30, 2024 | 216,383.00 |
| Mar 31, 2024 | 216,076.00 |
| Dec 31, 2023 | 214,866.00 |
| Sep 30, 2023 | 181,718.00 |
| Jun 30, 2023 | 181,640.00 |
| Mar 31, 2023 | 181,392.00 |
| Dec 31, 2022 | 180,682.00 |
| Sep 30, 2022 | 180,652.00 |
| Jun 30, 2022 | 179,888.00 |
| Mar 31, 2022 | 150,748.00 |
| Dec 31, 2021 | 150,372.00 |
| Sep 30, 2021 | 149,336.00 |
API Access
IRulya Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();